Entry Detail



General Information

Database ID:exR0839965
RNA Name:hsa-miR-132-5p
RNA Type:miRNA
Chromosome:chr17
Starnd:-
Coordinate:
Start Site(bp):2049965End Site(bp):2049986
External Links:hsa-miR-132-5p



Disease Information

Disease Name:Prostate Cancer
Disease Category:Cancers
MeSH ID:D011471
Type:Neoplasms/Digestive System Neoplasms
Alias:Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate



Expression Detail

GEO ID:GSE71008
Description:Plasma extracellular RNA profiles in healthy and cancer patients
Experimental Design:Cancer vs Control
Case Disease Type:Colorectal Cancer
Case Disease SubType:NA
Case Sample:Prostate Cancer
Control Sample:Healthy
Number of Case:100
Number of Control:50
Number of Samples:150





Regulatory Relationship

mRNA targets:NA
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007161.3
chr7
7640752
8004053
+
LINC02228
chr5
25087450
25190956
-
MIR34AHG
chr1
9148011
9198906
-
MIRLET7BHG
chr22
46053869
46113928
+
NORAD
chr20
36045618
36051018
-
OVCH1-AS1
chr12
29389289
29487488
+
SNHG16
chr17
76557764
76565348
+
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:26786760
Title:Plasma extracellular RNA profiles in healthy and cancer patients
Author:Yuan T, Huang X, Woodcock M, Du M, Dittmar R, Wang Y, Tsai S, Kohli M, Boardman L, Patel T, Wang L
Journal:Sci Rep. 2016 Jan 20;6:19413.
Description:we performed RNA sequencing analysis on plasma extracellular vesicles derived from 50 healthy individuals and 142 cancer patients.